It is recognized that Aβ and tau AD pathologies contribute to cortical thinning and clinical decline23, and observations have shown that phosphorylated tau-dependent cortical thinning occurs in amyloid-positive individuals64,65. This evidence concerns the gene MAPT and amyloidosis.